Literature DB >> 7987858

Long-term serum/plasma-free culture of human cytotoxic T lymphocytes induced from peripheral blood mononuclear cells.

S Q Liu1, R Shiba, B S Kim, K Saijo, T Ohno.   

Abstract

Tumor-specific human cytotoxic T lymphocytes (CTL) were induced by co-culturing peripheral blood mononuclear cells with X-ray-irradiated human lung squamous carcinoma cells, SQ-5, in the medium supplemented with interleukin(IL)-1, IL-2, IL-4 and IL-6, and 5% autologous plasma for 3 or 5 days. The CTL grew in serum/plasma-free medium containing these four interleukins and 0.5% bovine serum albumin for over a month and maintained killing activity of target cells within 48 h at an effector/target ratio of 1.25. Their growth was essentially dependent on the target SQ-5 cells, which were renewed every 5 days. Under these conditions, IL-4 and IL-6 could be omitted. When anti-CD3 monoclonal antibody was added to the serum/plasma-free medium supplemented with IL-1 and IL-2, the target tumor cells were not required to maintain the specific killing activity of the CTL. A large number of CTL (10(11)) were obtained in 35 days.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7987858     DOI: 10.1007/BF01519979

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  30 in total

1.  Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.

Authors:  Y Shimizu; E Weidmann; S Iwatsuki; R B Herberman; T L Whiteside
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

2.  IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.

Authors:  O M Martinez; R S Gibbons; M R Garovoy; F R Aronson
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

3.  The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.

Authors:  T L Darrow; C L Slingluff; H F Seigler
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

4.  Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.

Authors:  S A Rosenberg; P Aebersold; K Cornetta; A Kasid; R A Morgan; R Moen; E M Karson; M T Lotze; J C Yang; S L Topalian
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

5.  Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro.

Authors:  T Takahashi; H Ishikura; K Iwai; C Takahashi; H Kato; T Tanabe; T Yoshiki
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

6.  Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials.

Authors:  S L Topalian; L M Muul; D Solomon; S A Rosenberg
Journal:  J Immunol Methods       Date:  1987-08-24       Impact factor: 2.303

Review 7.  T cell recognition of human tumors: implications for molecular immunotherapy of cancer.

Authors:  C G Ioannides; T L Whiteside
Journal:  Clin Immunol Immunopathol       Date:  1993-02

8.  Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial.

Authors:  R I Fisher; C A Coltman; J H Doroshow; A A Rayner; M J Hawkins; J W Mier; P Wiernik; J D McMannis; G R Weiss; K A Margolin
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

9.  In vitro expansion of tumor-specific, HLA-restricted human CD8+ cytolytic T lymphocytes.

Authors:  M Nakashima; T Watanabe; H Koprowski; L Schuchter; Z Steplewski
Journal:  Cell Immunol       Date:  1994-04-15       Impact factor: 4.868

10.  Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones.

Authors:  T Wölfel; W Herr; P Coulie; U Schmitt; K H Meyer zum Büschenfelde; A Knuth
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

View more
  3 in total

1.  Induction of auto-logous human cytotoxic T lymphocytes (CTL) from peripheral blood against tumor cells.

Authors:  T Ohno
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

2.  Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18.

Authors:  M Kohyama; K Saijyo; M Hayasida; T Yasugi; M Kurimoto; T Ohno
Journal:  Jpn J Cancer Res       Date:  1998-10

3.  High rate of induction of human autologous cytotoxic T lymphocytes against renal carcinoma cells cultured with an interleukin cocktail.

Authors:  S Q Liu; K Kawai; H Shiraiwa; H Hayashi; H Akaza; K Hashizaki; R Shiba; K Saijo; T Ohno
Journal:  Jpn J Cancer Res       Date:  1998-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.